Life-Threatening Abnormal Behavior Incidence in 10–19 Year Old Patients Administered Neuraminidase Inhibitors

• Yuuki Nakamura,

  Affiliation Graduate School of Pharmacy, Nihon University, Funabashi, Chiba, Japan

  ⨯
• Tamie Sugawara,

  Affiliation Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Shinjuku, Tokyo, Japan

  ⨯
• Yasushi Ohkusa ,

  * E-mail: ohkusa@nih.go.jp

  Affiliation Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Shinjuku, Tokyo, Japan

  ⨯
• Kiyosu Taniguchi,

  Affiliation National Hospital Organization Mie National Hospital, Tsu, Mie, Japan

  ⨯
• Chiaki Miyazaki,

  Affiliation Fukuoka Welfare Center for the Disabled, Fukuoka, Fukuoka, Japan

  ⨯
• Mariko Momoi,

  Affiliation International University of Health and Welfare, Ohtawara, Tochigi, Japan

  ⨯
• Nobuhiko Okabe

  Affiliation Kawasaki City Institute for Public Health, Kawasaki, Kanagawa, Japan

  ⨯